The growing legalization of the plant in various countries and its adoption for the treatment of diseases is positively impacting market growth

In practice, Marconi established a total deadline of up to 4 months for Abrace to make the adjustments required by Anvisa, which, according to the federal agency, motivated the request for a suspension injunction that would interrupt the entity's work.

Meeting aligned strategies for the development of technical and scientific knowledge about the plant, focusing on its medicinal and industrial potential

Minister states that measures already taken temporarily prevent delays in the process of regulating industrial hemp in Brazil

The company, headquartered in Campinas, wants to take advantage of the path paved from RDC 327 and establish itself as an alternative in the Brazilian medicinal cannabis market with the development of studies, product launches, and, who knows, in the supply

General coordinator details the efforts made by the public agency

Document developed by a group with 31 Brazilian academic and research institutions points out regulatory barriers and suggests an agile framework to strengthen the scientific and technological sector

The decision came after a meeting with the management team of the State Agency of Medicines and Health Products (AEMPS)

A systematic review from Erasmus University in the Netherlands reveals the potential benefits and risks of medicinal cannabis in treating conditions such as anxiety, depression, and PTSD, highlighting the importance of personalized approaches in mental health.

On the anniversary of the National Health Surveillance Agency (Anvisa), learn about the evolution of the medicinal use of cannabis over the 23 years since the agency was created

Social Affairs Committee to analyze four names for leadership positions in health agencies

"Without regulation, there is no development," experts argue

Court authorization paves the way for personalized and more accessible products for the population

The Health Department of the Federal District has opened a bidding process for the purchase of cannabidiol-based medication, intended for patients with severe epilepsy treated by SUS-DF

Unesp researcher expands boundaries: Rogério Amorim leads studies on cannabis and cognitive dysfunction in dogs

Government and CEBRAPCAM unite science and social inclusion to strengthen public health in the region

The deputies want the government to answer six questions, one of them regarding the incorporation in the SUS of a specific product linked to only one manufacturer and not related to the active ingredient

Unprecedented analysis mapped lawsuits filed against the Union for access to treatments and aims to support public policies of the Ministry of Health regarding the increasing demand in the SUS

Event reaches its 4th edition with a focus on health, science, and cannabis regulation in Brazil

The goal is to replace criminal punishment with social support, expanding prevention and support services nationwide